Cite
HARVARD Citation
Sloot, S. et al. (2018). Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapies. Cancer. 124 (2), pp. 297-305. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sloot, S. et al. (2018). Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapies. Cancer. 124 (2), pp. 297-305. [Online].